Because CSF Chi3l1 is correlated with spinal cord volume loss, whereas CSF neurofilament light chain (NfL) is related to gray matter atrophy, these two biomarkers can provide complementary information for determining the course and prognosis of MS [193]. This evidence concerns the gene CSF2 and myeloid sarcoma.